Validity and Reliability of the Six-Minute Walking Test Compared to Cardiopulmonary Exercise Test in Individuals with

Garyfallia Pepera1, Varsamo Antoniou1, Eleni Karagianni1

  • 1Clinical Exercise Physiology and Rehabilitation Research Laboratory, Department of Physiotherapy, Faculty of Health Sciences, University of Thessaly, 35132 Lamia, Greece.

PubMed

Insights

The 6-minute walk test (6MWT) is a valid and reliable measure of cardiorespiratory fitness in heart failure (HF) patients, correlating well with cardiopulmonary exercise testing (CPET) and showing excellent test-retest reliability. It serves as a practical alternative or complement to CPET for assessing HF patients.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Rehabilitation Medicine

Background:

  • Reduced cardiorespiratory fitness and exercise tolerance are key predictors of morbidity and mortality in heart failure (HF).
  • Cardiopulmonary exercise testing (CPET) is the gold standard but can be complex and poorly tolerated by HF patients.
  • The 6-minute walk test (6MWT) offers a simpler, well-tolerated alternative for assessing exercise capacity.

Purpose of the Study:

  • To systematically review the validity, reliability, and safety of the 6MWT compared to CPET in patients with heart failure.
  • To determine the correlation between 6MWT distance and CPET-derived peak oxygen consumption (VO2).
  • To assess the test-retest reliability and learning effect of the 6MWT in HF patients.

Main Methods:

  • Systematic review and meta-analysis of studies comparing 6MWT and CPET in HF patients.
  • Searched Embase, Medline, and Scopus databases up to November 2023.
  • Pooled correlation coefficients (Fisher's z-transformation) and reliability measures (intraclass correlation coefficient) using random-effects models.

Main Results:

  • Twenty studies involving 5379 HF participants were included.
  • A moderately strong positive correlation was found between 6MWT distance and CPET peak VO2 (r = 0.62).
  • Excellent test-retest reliability (ICC = 0.93) and a small learning effect (15.5 m) were observed for the 6MWT, with no serious adverse events reported.

Conclusions:

  • The 6MWT is a valid measure of cardiorespiratory fitness in HF, correlating well with CPET peak VO2.
  • The 6MWT demonstrates excellent reliability and is safe for use in HF patients.
  • The 6MWT can serve as a practical complementary or alternative assessment to CPET when CPET is not feasible.

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
396
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
296
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
729